Cognitive Impairment Is Part of the Phenotype of Cerebellar Ataxia, Neuropathy, Vestibular Areflexia Syndrome (CANVAS)

Mov Disord. 2024 May;39(5):892-897. doi: 10.1002/mds.29750. Epub 2024 Mar 13.

Abstract

Background: Little is known about the impact of the cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) on cognition.

Objective: Our objective was to determine the frequency and severity of cognitive impairment in RFC1-positive patients and describe the pattern of deficits.

Methods: Participants underwent a comprehensive neuropsychological assessment. Volume of the cerebellum and its lobules was measured in those who underwent a 3 Tesla-magnetic resonance scan.

Results: Twenty-one patients underwent a complete assessment, including 71% scoring lower than the cutoff at the Montreal Cognitive assessment and 71% having a definite cerebellar cognitive affective/Schmahmann syndrome. Three patients had dementia and seven met the criteria of mild cognitive impairment. Severity of cognitive impairment did not correlate with severity of clinical manifestations. Performance at memory and visuospatial functions tests negatively correlated with the severity of cerebellar manifestations.

Conclusion: Cognitive manifestations are frequent in RFC1-related disorders. They should be included in the phenotype and screened systematically. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keywords: RFC1‐gene; cerebellum; cognitive impairment; inherited ataxia; neuropathy.

MeSH terms

  • Adult
  • Aged
  • Cerebellar Ataxia* / complications
  • Cerebellar Ataxia* / physiopathology
  • Cerebellum / diagnostic imaging
  • Cerebellum / pathology
  • Cerebellum / physiopathology
  • Cognitive Dysfunction* / etiology
  • Cognitive Dysfunction* / physiopathology
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Phenotype*
  • Replication Protein C / genetics
  • Vestibular Diseases / physiopathology

Substances

  • RFC1 protein, human